A selective glucocorticoid receptor modulator attenuates lung inflammation and improves alveolarization in a neonatal rat model of bronchopulmonary dysplasia.
S. Ishikawa, T. Ogihara, S. Yamaoka, J. Shinohara, S. Kawabata, Y. Hirose, A. Ashida
This study shows that Compound A reduces lung inflammation and improves alveolarization in a neonatal rat model of bronchopulmonary dysplasia.
bioRxiv · Apr 28, 2021 · PreprintPathology